ReviewMini reviews in medicinal chemistry2025
The Role of 3D Printing in Revolutionizing Pharmaceuticals and Medicine.
Review in Mini reviews in medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three-dimensional (3D) printing is a transformative technology that has significantly influenced multiple sectors, including aviation, defence, architecture, and, more recently, healthcare and pharmaceuticals. Despite its growing adoption, there remain gaps in consolidated knowledge regarding its material versatility, regulatory considerations, and real-world implementation in clinical and pharmaceutical settings. Challenges related to biocompatibility, scalability, and the standardization of printed products hinder its full integration into medical practice. Addressing these issues requires a comprehensive understanding of the technological foundation, materials, and evolving applications of 3D printing in medicine. This review aims to provide an in-depth analysis of current advances, limitations, and prospects of 3D printing in healthcare. A systematic literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar databases, focusing on peer-reviewed articles published between 2010 and 2024. The review highlights key fabrication techniques, material innovations, clinical applications, and integration with emerging technologies, addressing critical challenges and opportunities for advancing personalized medicine.
Indexed as
Identifiers
41114493What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.